USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
Annual CT screening recommended for patients aged 50 to 80 years at high risk for lung cancer from smoking.
Lung Cancer
Prior PD-1 Blockade Did Not Appear to Affect COVID-19 Severity in Lung Cancer
There have been some concerns that the immunomodulatory effect of PD-1 blockade may influence the response of patients with cancer to COVID-19.
Quality of Life Worse for Patients With Cancer During COVID-19
Quality of life was significantly lower in patients with cancer than reference group.
Bodyweight-Based Dosing of Nivolumab Results in Wastage
A review of practices prior to a change in nivolumab dosing demonstrated that bodyweight dosing resulted in a 6.1% rate of wastage at a significant cost compared with a fixed dose of 240 mg per dose.
Racial Disparities Seen in PET/CT Imaging for Lung Cancer
Black and Hispanic patients are less likely to receive recommended imaging at time of diagnosis of NSCLC.
Lurbinectedin Approved for Metastatic Small Cell Lung Cancer
The FDA has approved lurbinectedin for the treatment of adult patients with metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy.
FDA Approves Pembrolizumab for Tumor Mutational Burden-High Cancer
The accelerated approval was based on data from a prospectively-planned retrospective analysis of 10 cohorts of patients with various previously treated unresectable or metastatic solid tumors with TMB-H who were enrolled in the open-label phase 2 KEYNOTE-158 trial.
COVID-19 Death Rate High for Patients With Thoracic Cancer
SARS-CoV-2 infection is associated with high mortality in patients with thoracic cancer.
Ramucirumab Plus Erlotinib Approved for First-Line Metastatic NSCLC With EGFR Mutations
The FDA has approved ramucirumab in combination with erlotinib, for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations.
Smoking Cessation Programs in Lung Cancer Clinics Associated With Improved Survival
Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.
-
Loading...
-
Loading...
